임상 한눈에 보기

• 6건의 ClinicalTrials.gov 임상 기록
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• Phase: Phase 2 · Phase 3 · Phase 1
• Status: Completed · Unknown status · Terminated
• 주요 endpoint: Proportion of Participants Alive and Without Mechanical Ventilation Through Day 29 in Participants With Baseline Ordinal Score of 5 or 6 · C-reactive Protein (CRP)<150mg/L and Age <85 Years · Proportion of Participants Alive and Without Mechanical Ventilation Through Day 29 in Participants With Any Baseline Ordinal Score · Time to Sustained Recovery in Participants With a Baseline Ordinal Score of 5 or 6 · CRP<150mg/L and Age <85 Years
• 등록 대상자(표본 합산): 약 1,518명
• 선택한 코호트 보고값: ORR 9.9%
• 핵심: The primary objectives of this study are: Phase 1: To evaluate the safety of sequenced therapy with lenzilumab and axic…

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.